Haploidentical Allogeneic Stem Cell Transplantation in Sickle Cell Disease: A Systematic Review and Meta-Analysis

This publication has 28 references indexed in Scilit:

• Infections after T‐replete haploidentical transplantation and high‐dose cyclophosphamide as graft‐versus‐host disease prophylaxis
  Transplant Infectious Disease, 2015
• HLA Match Likelihoods for Hematopoietic Stem-Cell Grafts in the U.S. Registry
  New England Journal of Medicine, 2014
• Long-Term Outcome and Evaluation of Organ Function in Pediatric Patients Undergoing Haploidentical and Matched Related Hematopoietic Cell Transplantation for Sickle Cell Disease
  Transplantation and Cellular Therapy, 2013
• HLA-haploidentical bone marrow transplantation with posttransplant cyclophosphamide expands the donor pool for patients with sickle cell disease
  Blood, 2012
• The inherited diseases of hemoglobin are an emerging global health burden
  Blood, 2010
• Safety and efficacy of targeted busulfan therapy in children undergoing myeloablative matched sibling donor BMT for sickle cell disease
  Bone Marrow Transplantation, 2010
• Graft-versus-host disease
  The Lancet, 2009
• Reduced-Intensity Conditioning Regimen Workshop: Defining the Dose Spectrum. Report of a Workshop Convened by the Center for International Blood and Marrow Transplant Research
  Transplantation and Cellular Therapy, 2009
• Second EBMT Workshop on reduced intensity allogeneic hemopoietic stem cell transplants (RI-HSCT)
  Bone Marrow Transplantation, 2002
• Bone Marrow Transplantation for Sickle Cell Disease
  New England Journal of Medicine, 1996